Evidence map›Paper›PMID 34025428›Full record

ArticleFrontiers in pharmacology2021

Downregulated MicroRNA-327 Attenuates Oxidative Stress-Mediated Myocardial Ischemia Reperfusion Injury Through Regulating the FGF10/Akt/Nrf2 Signaling Pathway.

Tao Zheng, Jun Yang, Jing Zhang, Chaojun Yang, Zhixing Fan, Qi Li, Yuhong Zhai, Haiyin Liu, Jian Yang

Open access · goldAbstract read
In one paragraph

Article in Frontiers in pharmacology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 24 citations in OpenAlex.

  1. LILRB4 Recruits SHP-1 to Enhance Oxidative Stress and Apoptosis, Aggravating Myocardial Ischemia-Reperfusion Injury.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Article
  2. Potential ofFrontiers in immunology · 2026
    Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Tao ZhengDepartment of Cardiology, the First College of Clinical Medical Science, China Three Gorges University, Yichang, China.
Jun YangDepartment of Cardiology, the First College of Clinical Medical Science, China Three Gorges University, Yichang, China.
Jing ZhangDepartment of Cardiology, the First College of Clinical Medical Science, China Three Gorges University, Yichang, China.
Chaojun YangYichang Key Laboratory of Ischemic Cardiovascular and Cerebrovascular Disease Translational Medicine, Yichang, China.
Zhixing FanYichang Key Laboratory of Ischemic Cardiovascular and Cerebrovascular Disease Translational Medicine, Yichang, China.
Qi LiInstitute of Cardiovascular Disease, China Three Gorges University, Yichang, China.
Yuhong ZhaiDepartment of Cardiology, the First College of Clinical Medical Science, China Three Gorges University, Yichang, China.
Haiyin LiuDepartment of Cardiology, the First College of Clinical Medical Science, China Three Gorges University, Yichang, China.
Jian YangDepartment of Cardiology, the People's Hospital of Three Gorges University, Yichang, China.
China Three Gorges University · CNSecond Hospital of Yichang · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Although miR-327 had a protective effect on cardiomyocytes as described previously, the potential mechanism still needs further exploration. The aim of this study was to investigate the role and mechanism of miR-327 on oxidative stress in myocardial ischemia/reperfusion injury (MI/RI) process. Oxidative stress and cardiomyocytes injury were detected in rat model of MI/RI, hypoxia/reoxygenation (H/R), and tert-butyl hydroperoxide (TBHP) model of H9c2 cells.

Indexed as

apoptosisFGF10microRNA-327myocardial ischemia/reperfusion injuryoxidative stress

Identifiers

PMID34025428
PMCPMC8138475
OpenAlexW3159004822

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.